Table 4.
Variable | Overall | Traveled in the prior 3 months |
Did not travel in the prior 3 months |
p-value (unadjusted) |
Adjusted OR for travel (95% CI) |
---|---|---|---|---|---|
Used (injected/snorted/smoked) methamphetamine, among those under age 22.5 (n=178) Yes No |
70.8% 29.2% |
70.4% 29.6% |
71.7% 28.3% |
0.86 |
0.95 (0.46-1.97) --- |
Used (injected/snorted/smoked) methamphetamine, among those age 22.5 and older (n=177) Yes No |
72.3% 27.7% |
63.5% 36.5% |
82.7% 17.3% |
<0.01 |
0.34 (0.17-0.71) --- |
Pooled money to buy drugs among those injecting for <5 years (n=173) Yes No |
80.2% 19.8% |
88.8% 11.2% |
62.5% 37.5% |
<0.01 |
4.56 (2.00-10.41) --- |
Pooled money to buy drugs among those injecting for ≥5 years (n=182) Yes No |
77.5% 22.5% |
83.8% 16.2% |
68.8% 31.2% |
0.02 |
2.26 (1.09-4.70) --- |
Syringe was backloaded among those under age 22.5 (n=178) Yes No |
56.9% 43.1% |
63.6% 36.4% |
41.5% 58.5% |
<0.01 |
2.35 (1.19-4.67) --- |
Syringe was backloaded among those age 22.5 and older (n=177) Yes No |
56.8% 43.2% |
61.5% 38.5% |
51.3% 48.7% |
0.17 |
1.46 (0.79-2.70) --- |
HCV antibody positive, among those younger than age 22.5 (n=178) Yes No |
25.4% 74.6% |
31.2% 68.9% |
11.8% 88.2% |
<0.01 |
3.21 (1.18-8.73) --- |
HCV antibody positive, among those age 22.5 and older (n=177) Yes No |
42.1% 57.9% |
40.6% 59.4% |
43.8% 56.2% |
0.68 |
0.71 (0.37-1.40) --- |